The gene sequencing technology developer has been spun out of Harvard University with $23m in series A capital provided by investors including Eli Lilly.

Merck Sharp & Dohme and Wayra UK have joined forces again to welcome a second cohort to their digital health accelerator program Velocity Health.

The gene sequencing technology developer has been spun out of Harvard University with $23m in series A capital provided by investors including Eli Lilly.

The pharmaceutical company's Lilly Asia Ventures unit was among the investors for the first round closed by the immuno-oncology startup.

Fosun and DXY have co-led series A and A+ rounds for LinkedCare, which operates a cloud-based platform for dentists and patients.

UC San Francisco spinout Fortis Therapeutics has closed an $18m series A round backed by Osage University Partners and an investment subsidiary of Eli Lilly.

The healthcare system has joined venture capital firm Rev1 Ventures for a unit that will invest in life sciences spinouts from its research institute.